Cerebral Amyloid Angiopathy, Subcortical White Matter Disease and Dementia: Literature Review and Study in OPTIMA
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Cerebral amyloid angiopathy (CAA) is of increasing clinical and research interest as the ability to detect it and its consequences by neuroimaging in living subjects has advanced. There is also increasing interest in understanding its possible role in the development of intracerebral hemorrhage, A lzheimer's disease (AD) and vascular dementia. In this article, the literature on this subject is reviewed and novel findings relating CAA to subcortical white matter damage in 224 subjects in the O xford project to I nvestigate M emory and A geing (OPTIMA) are reported. The relationship between CAA and subcortical tissue damage in the OPTIMA subjects was found to be critically dependent on ApoE genotype, there being a positive relationship between measures of CAA and subcortical small vessel disease in ApoEε4 carriers and a significant negative relationship in ApoEε2 carriers. These findings draw attention, as have many other studies, to the importance of ApoE genotype as a major risk factor not only for dementia but also for damage to blood vessels in the aging brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Cerebral microbleeds: a guide to detection and interpretation
Greenberg, S. M., Vernooij, M. W., Cordonnier, C., Viswanathan, A., Al-Shahi Salman, R., Warach, S., Launer, L. J., Van Buchem, M. A., & Breteler, M. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70013-4 · Cited by 1,798
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · cited 1×
“Such vaccine treatment was associated with an increase in CAA and evidence on MRI of white matter edema (13, 33, 79), now more fully characterized as amyloid-related imaging abnormalities (8, 124).”
Background(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy
Linn, J., Halpin, A., Demaerel, P., Ruhland, J., Giese, A. D., Dichgans, M., van Buchem, M. A., Bruckmann, H., & Greenberg, S. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dad605 · Cited by 914
Apolipoprotein E in Alzheimer’s disease and other neurological disorders
Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70325-2 · Cited by 857 · cited 13×
“This effect of different ApoE isoforms mirrored the effect of intracranial administration of amyloidβ to mice transfected with different human ApoE genotypes in which shedding of lipoprotein receptors was greatest with ApoEε4, followed by ApoEε3 and then ApoEε2.”
BackgroundInfluentialPrevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study
Vernooij, M. W., van der Lugt, A., Ikram, M. A., Wielopolski, P. A., Niessen, W. J., Hofman, A., Krestin, G. P., & Breteler, M. M. B. (2008) · Neurology · doi:10.1212/01.wnl.0000307750.41970.d9 · Cited by 793
apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · cited 2×
“Binding of amyloidβ to ApoE dramatically reduces the clearance of amyloidβ from the brain via the blood probably by influencing the manner in which amyloidβ interacts with receptors that facilitate clearance of amyloidβ from brain through the blood–brain barrier (10, 25, 69).”
BackgroundAlzheimer disease and cerebrovascular pathology: an update
Jellinger, K. A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200068 · Cited by 680 · cited 1×
“These structural changes impair the capacity of affected vessels to supply tissues with the blood they need and lead to cortical infarction and intracerebral hemorrhage in some subjects (15, 28, 50, 54, 81, 82).”
BackgroundBell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670 · cited 1×
“Binding of amyloidβ to ApoE dramatically reduces the clearance of amyloidβ from the brain via the blood probably by influencing the manner in which amyloidβ interacts with receptors that facilitate clearance of amyloidβ from brain through the blood–brain barrier (10, 25, 69).”
BackgroundCerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study
Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662
Cerebral amyloid angiopathy in the elderly
Viswanathan, A., & Greenberg, S. M. (2011) · Annals of Neurology · doi:10.1002/ana.22516 · Cited by 643
Charidimou, A., Gang, Q., & Werring, D. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301308 · Cited by 611 · cited 3×
“CAA has long been recognized to be associated with secondary structural changes of which inflammation, fibrinoid necrosis, microaneurysm formation, thrombosis and detachment of the tunica media from the tunica adventitia, giving an impression of duplication of the vessel lumen “double barreling,” are the most common (…”
BackgroundEllis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A. (1996) · Neurology · doi:10.1212/wnl.46.6.1592 · Cited by 561
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., Smith, E. E., Rosand, J., Rentz, D. M., Klunk, W. E., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21164 · Cited by 495 · cited 1×
“A further potential source of additional information is the use of an amyloid-binding marker such as Pittsburgh Compound B (PIB) to detect beta amyloid in living subjects with which it is possible to obtain an impression of the extent of CAA (43, 55, 63, 66).”
BackgroundTwo Types of Sporadic Cerebral Amyloid Angiopathy
Thal, D. R., Ghebremedhin, E., Rüb, U., Yamaguchi, H., Del Tredici, K., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.282 · Cited by 446
Clinical manifestations of cerebral amyloid angiopathy–related inflammation
Eng, J. A., Frosch, M. P., Choi, K., Rebeck, G. W., & Greenberg, S. M. (2004) · Annals of Neurology · doi:10.1002/ana.10810 · Cited by 417 · cited 1×
“It is clinically expressed by a relatively rapidly progressing cognitive impairment, seizures, behavioral changes, neurological deficits and headaches (24, 29, 59, 95, 104).”
BackgroundApolipoprotein e sets the stage: response to injury triggers neuropathology
Mahley, R. W., & Huang, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.11.020 · Cited by 412
Calhoun, M. E., Burgermeister, P., Phinney, A. L., Stalder, M., Tolnay, M., Wiederhold, K.-H., Abramowski, D., Sturchler-Pierrat, C., Sommer, B., Staufenbiel, M., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14088 · Cited by 410 · cited 1×
“These include a study showing that AD transgenic mice with APP overexpressed under the control of a neuronal promoter (thus providing only a neuronal source of amyloidβ) was sufficient to cause CAA (16), and a transgenic AD mouse model that showed that reduction of cerebral blood flow impaired drainage of interstitial…”
BackgroundThal, D. R., Ghebremedhin, E., Orantes, M., & Wiestler, O. D. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1287 · Cited by 384 · cited 2×
“The first possibility is raised by the suggestion of Grinberg and Thal (46) and Thal et al (111) that SVD may exert added pressure on the perivascular drainage system and lead to enhanced CAA.”
ResultCerebral amyloid angiopathy pathology and cognitive domains in older persons
Arvanitakis, Z., Leurgans, S. E., Wang, Z., Wilson, R. S., Bennett, D. A., & Schneider, J. A. (2011) · Annals of Neurology · doi:10.1002/ana.22112 · Cited by 383 · cited 1×
“After taking account of AD pathology, moderate-to-severe CAA was independently related to lower perceptual speed and episodic memory (2).”
BackgroundScolding, N. J. (2005) · Brain · doi:10.1093/brain/awh379 · Cited by 372
Review: sporadic cerebral amyloid angiopathy
Attems, J., Jellinger, K., Thal, D. R., & Van Nostrand, W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01137.x · Cited by 371 · cited 5×
“CAA has long been recognized to be associated with secondary structural changes of which inflammation, fibrinoid necrosis, microaneurysm formation, thrombosis and detachment of the tunica media from the tunica adventitia, giving an impression of duplication of the vessel lumen “double barreling,” are the most common (…”
BackgroundMethodInfluentialPlasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
Gurol, M. E., Irizarry, M. C., Smith, E. E., Raju, S., Diaz-Arrastia, R., Bottiglieri, T., Rosand, J., Growdon, J. H., & Greenberg, S. M. (2006) · Neurology · doi:10.1212/01.wnl.0000191403.95453.6a · Cited by 339 · cited 1×
“Gurol et al (47) examined T2 white matter hyperintensities (WMH) in magnetic resonance imagings (MRIs) on 54 AD or mild cognitive impairment (MCI) cases and 42 cases with probable CAA diagnosed using the Boston criteria that rely on a history of lobar intracerebral hemorrhage and absence of any other clear cause of in…”
MethodCerebral amyloid angiopathy and cognitive function: The HAAS autopsy study
Pfeifer, L. A., White, L. R., Ross, G. W., Petrovitch, H., & Launer, L. J. (2002) · Neurology · doi:10.1212/wnl.58.11.1629 · Cited by 338 · cited 1×
“In the Honolulu-Asia study of aging in JapaneseAmerican men, it was concluded that cases of AD with CAA had lower cognitive scores than those without CAA (85).”
BackgroundCourse of cerebral amyloid angiopathy–related inflammation
Kinnecom, C., Lev, M. H., Wendell, L., Smith, E. E., Rosand, J., Frosch, M. P., & Greenberg, S. M. (2007) · Neurology · doi:10.1212/01.wnl.0000260066.98681.2e · Cited by 333 · cited 1×
“It is clinically expressed by a relatively rapidly progressing cognitive impairment, seizures, behavioral changes, neurological deficits and headaches (24, 29, 59, 95, 104).”
BackgroundStaging and natural history of cerebrovascular pathology in dementia
Deramecourt, V., Slade, J. Y., Oakley, A. E., Perry, R. H., Ince, P. G., Maurage, C.-A., & Kalaria, R. N. (2012) · Neurology · doi:10.1212/wnl.0b013e31824e8e7f · Cited by 309
Neuropathologic Substrates of Ischemic Vascular Dementia
Vinters, H. V., Ellis, W. G., Zarow, C., Zaias, B. W., Jagust, W. J., Mack, W. J., & Chui, H. C. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.11.931 · Cited by 304
PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., Libri, V., Leppert, D., & Beach, T. G. (2007) · Brain · doi:10.1093/brain/awm191 · Cited by 302
Amyloid Angiopathy–Related Vascular Cognitive Impairment
Greenberg, S. M., Gurol, M. E., Rosand, J., & Smith, E. E. (2004) · Stroke · doi:10.1161/01.str.0000143224.36527.44 · Cited by 298
Weller, R. O., Boche, D., & Nicoll, J. A. R. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0498-z · Cited by 297
Fryer, J. D., Simmons, K., Parsadanian, M., Bales, K. R., Paul, S. M., Sullivan, P. M., & Holtzman, D. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5170-04.2005 · Cited by 278 · cited 2×
“In a subsequent study Fryer et al (36) showed that AD mice transfected with the gene for human ApoEε3 developed few cortical amyloidβ plaques and CAA.”
BackgroundAssociation of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy
Greenberg, S. M., Vonsattel, J.-P. G., Segal, A. Z., Chiu, R. I., Clatworthy, A. E., Liao, A., Hyman, B. T., & Rebeck, G. W. (1998) · Neurology · doi:10.1212/wnl.50.4.961 · Cited by 267
Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts
Okamoto, Y., Yamamoto, T., Kalaria, R. N., Senzaki, H., Maki, T., Hase, Y., Kitamura, A., Washida, K., Yamada, M., Ito, H., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0925-9 · Cited by 249 · cited 2×
“These structural changes impair the capacity of affected vessels to supply tissues with the blood they need and lead to cortical infarction and intracerebral hemorrhage in some subjects (15, 28, 50, 54, 81, 82).”
BackgroundMirra, S. S. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00058-4 · Cited by 236
Olichney, J. M., Hansen, L. A., Galasko, D., Saitoh, T., Hofstetter, C. R., Katzman, R., & Thal, L. J. (1996) · Neurology · doi:10.1212/wnl.47.1.190 · Cited by 216
Carare, R. O., Hawkes, C. A., Jeffrey, M., Kalaria, R. N., & Weller, R. O. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12042 · Cited by 207
Kim, J., Jiang, H., Park, S., Eltorai, A. E. M., Stewart, F. R., Yoon, H., Basak, J. M., Finn, M. B., & Holtzman, D. M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3773-11.2011 · Cited by 204 · cited 1×
“Reducing the ability of ApoE to interact with amyloidβ by administration of an anti-ApoE antibody or by overexpression of LDLR diminishes the build-up of amyloidβ as cortical plaques in animal models of AD (58, 100, 101).”
BackgroundClinical Significance of Microbleeds in Subcortical Vascular Dementia
Won Seo, S., Hwa Lee, B., Kim, E.-J., Chin, J., Sun Cho, Y., Yoon, U., & Na, D. L. (2007) · Stroke · doi:10.1161/strokeaha.106.477315 · Cited by 185
Sadowski, M. J., Pankiewicz, J., Scholtzova, H., Mehta, P. D., Prelli, F., Quartermain, D., & Wisniewski, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604011103 · Cited by 167 · cited 1×
“Reducing the ability of ApoE to interact with amyloidβ by administration of an anti-ApoE antibody or by overexpression of LDLR diminishes the build-up of amyloidβ as cortical plaques in animal models of AD (58, 100, 101).”
BackgroundTopography of dilated perivascular spaces in subjects from a memory clinic cohort
Martinez-Ramirez, S., Pontes-Neto, O. M., Dumas, A. P., Auriel, E., Halpin, A., Quimby, M., Gurol, M. E., Greenberg, S. M., & Viswanathan, A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f1876 · Cited by 163 · cited 1×
“Martinez-Ramirez et al (70) found more severely dilated perivascular spaces in white matter in a group of 89 subjects attending a memory clinic and having MCI if they also had evidence of lobar microbleeds, a marker of CAA.”
BackgroundMcCarron, M. O., Nicoll, J. A. R., Stewart, J., Ironside, J. W., Mann, D. M. A., Love, S., Graham, D. I., & Dewar, D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199907000-00005 · Cited by 160
11 C-PIB binding is increased in patients with cerebral amyloid angiopathy–related hemorrhage
Ly, J. V., Donnan, G. A., Villemagne, V. L., Zavala, J. A., Ma, H., O'Keefe, G., Gong, S. J., Gunawan, R. M., Saunder, T., Ackerman, U., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cef7e3 · Cited by 157
Chalmers, K., Wilcock, G. K., & Love, S. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00457.x · Cited by 156
Self-citationSadowski, M., Pankiewicz, J., Scholtzova, H., Ripellino, J. A., Li, Y., Schmidt, S. D., Mathews, P. M., Fryer, J. D., Holtzman, D. M., Sigurdsson, E. M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63355-x · Cited by 154 · cited 1×
“Reducing the ability of ApoE to interact with amyloidβ by administration of an anti-ApoE antibody or by overexpression of LDLR diminishes the build-up of amyloidβ as cortical plaques in animal models of AD (58, 100, 101).”
BackgroundAPOE-ε2 and APOE-ε4 Correlate With Increased Amyloid Accumulation in Cerebral Vasculature
Nelson, P. T., Pious, N. M., Jicha, G. A., Wilcock, D. M., Fardo, D. W., Estus, S., & Rebeck, G. W. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31829a25b9 · Cited by 150
Incidence of cerebral microbleeds in preclinical Alzheimer disease
Yates, P. A., Desmond, P. M., Phal, P. M., Steward, C., Szoeke, C., Salvado, O., Ellis, K. A., Martins, R. N., Masters, C. L., Ames, D., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000285 · Cited by 150 · cited 2×
“Yates et al (127) followed up 174 subjects with MRI and PIB over 3 years and found CMBs in 18.6% of controls, 24.3% of those with MCI and 40% of those with AD.”
BackgroundInfluentialMartel, C. L., Mackic, J. B., Matsubara, E., Governale, S., Miguel, C., Miao, W., McComb, J. G., Frangione, B., Ghiso, J., & Zlokovic, B. V. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69051995.x · Cited by 149
Smallwood, A., Oulhaj, A., Joachim, C., Christie, S., Sloan, C., Smith, A. D., & Esiri, M. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01221.x · Cited by 127 · cited 5×
“The cases with definite AD were included in a study of 161 cases of AD in which the findings regarding subcortical vascular pathology (SVD) were reported (31), and all the other cases were included in an earlier study of SVD (106).”
BackgroundMethodResultInfluentialSelf-citationZago, W., Schroeter, S., Guido, T., Khan, K., Seubert, P., Yednock, T., Schenk, D., Gregg, K. M., Games, D., Bard, F., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.010 · Cited by 75
Esiri, M. M., Joachim, C., Sloan, C., Christie, S., Agacinski, G., Bridges, L. R., Wilcock, G. K., & Smith, A. D. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31829b72f1 · Cited by 42
Self-citation
Cited by
Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons
Boyle, P. A., Yu, L., Nag, S., Leurgans, S., Wilson, R. S., Bennett, D. A., & Schneider, J. A. (2015) · Neurology · doi:10.1212/wnl.0000000000002175 · Cited by 423
The role of APOE in cerebrovascular dysfunction
Tai, L. M., Thomas, R., Marottoli, F. M., Koster, K. P., Kanekiyo, T., Morris, A. W. J., & Bu, G. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1547-z · Cited by 231
“APOE2 and APOE4 increase cerebral amyloid angiopathy (CAA) CAA is the deposition of proteins, including Aβ (particularly Aβ40), in the leptomeningeal medium and small arteries, cortical arterioles and capillaries and is frequently observed with aging.”
InfluentialImpact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s disease
Shinohara, M., Murray, M. E., Frank, R. D., Shinohara, M., DeTure, M., Yamazaki, Y., Tachibana, M., Atagi, Y., Davis, M. D., Liu, C.-C., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1580-y · Cited by 123
Weaver, N. A., Doeven, T., Barkhof, F., Biesbroek, J. M., Groeneveld, O. N., Kuijf, H. J., Prins, N. D., Scheltens, P., Teunissen, C. E., van der Flier, W. M., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.001 · Cited by 71
“, 2018) and CAA vascular pathology is most abundant in blood vessels located in posterior brain regions (Esiri et al., 2015; Reijmer et al., 2016).”
BackgroundInteraction between cerebrovascular disease and Alzheimer pathology
Saito, S., & Ihara, M. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000239 · Cited by 69
Metadata
- Authors
- Esiri, M., Chance, S., Joachim, C., Warden, D., Smallwood, A., Sloan, C., Christie, S., Wilcock, G., & Smith, A. D.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2014-12-17
- Volume
- 25
- Issue
- 1
- Pages
- 51-62
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W1537321255
- Cited by
- 55
- References
- 55
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.